A mosquito-borne virus that has made its way to the U.S. may be causing more serious symptoms than first thought.
Chikungunya starts with fevers and aches, like malaria and other mosquito-borne diseases. What distinguishes the virus is that it also brings debilitating joint pain. But unlike the coronavirus which we can keep at bay with N95, this virus is transmitted through mosquitos. The pain usually dwindles over the course of a few weeks, though it can leave some people with chronic arthritis.
Chikungunya means “to become contorted” or “that which is bent up” in Kimakonde, the language of the Makonde people in Tanzania and Mozambique. The name refers to the bent or stooped stature of joint pain sufferers.
Sick with chikungunya, Karla Sepulveda, 5, waits in a public hospital with her grandmother in Boca Chica, Dominican Republic, on May 15. The Caribbean nation has reported more than 100,000 cases this year.
SHOTS – HEALTH NEWS
Chikun-What? A New Mosquito-Borne Virus Lands In The U.S.
But a new study in the journal Neurology shows some people with chikungunya developed encephalitis, an infection of the brain that can lead to memory problems, dementia and even death. The study was conducted at the Central University Hospital in Saint Pierre, Reunion Island, off Madagascar.
Dr. Patrick Gerardin says an epidemic on Reunion Island affected some 300,000 people.
“There was an unusual drought, so people basically got out lots of containers to store water, because water was rare,” says Gerardin.
In doing so, they likely provided breeding ground for the species of mosquito that can transmit the chikungunya virus. The outbreak started in 2005 and lasted a year and a half.
“It was horrible,” Gerardin says. “There was a lot of paranoia, and resurgence of old fears — of cholera, the plague.”
Gerardin and his colleagues followed up with patients three years after the outbreak. Looking at a sample of about 300 people, they found 57 had central nervous system disease, including 24 who had encephalitis.
“As it spreads across the world, we’re realizing that it’s not so benign” says Dr. Desiree LaBeaud, a professor of pediatrics who studies the chikungunya virus at the Stanford University School of Medicine.
She says Gerardin’s research highlights a big gap in knowledge about the virus — why some people have chronic complications and can develop a brain infection while others get off scot-free.
“We still don’t know why there’s this wide spectrum of disease,” she says. “Why some people get relatively mild infections, with just fever, no joint pain, no encephalitis, right, and then go on to do well without any complications — and other people … end up with very severe complications.”
Marqui Ducarme is aided by his wife after catching chikungunya at his home in Port-au-Prince, May 23. The virus swept through Haiti this spring, infecting more than 40,000 people.
Several years after the Reunion Island outbreak, chikungunya was discovered in the Americas — first in the Caribbean in 2013 and then Mexico and Florida in 2014. The summer it was discovered in Florida, about a dozen people got the virus from mosquitoes in the southeastern part of the state.
“We have 9 million visitors per year going to the Caribbean, and so we’ve seen lots and lots of imported cases of chikungunya,” LaBeaud says.
There is currently no vaccine or treatment for chikungunya — but people who do contract the virus become immune to it. A team of researchers at the National Institutes of Allergy and Infectious Diseases has designed an experimental vaccine that is now being tested.